Anthem Blue Cross (HMO, PPO, EPO)
Sunosi (solriamfetol)
Drugs for the Nervous System : Drugs for Sleep Disorder
  • Prior Authorization: EDS due to OSA:
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 1 year(s)

    Narcolepsy Type 1, Narcolepsy Type 2:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Age Requirement: >= 18
    Duration: 1 year(s)

  • PA Applies
  • EDS due to OSA:
    Age Requirement: >= 18
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Narcolepsy Type 1, Narcolepsy Type 2:
    Age Requirement: >= 18
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A

    Neurology: Narcolepsy:
    Age Requirement: >= 18
    Duration: 1 year(s)
    Medical Test Required: Yes
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Number of Episodes of Cataplexy Required in Policy: > 1
    Documented Duration of Daily EDS Occurrences: >= 3 month(s)
    Policy Criteria Required to Document Patient Multiple Sleep Latency Test (MSLT): 1 of MSLT < 8 min with evidence of 2 Soremps;MSLT with evidence of >= 1 SOREMP's and SOREMP, 15 min from preceding night polysomnography (PSG)
    Other causes of sleepiness have been ruled out.: Yes
    Patient must have CSF hypocretin 1 deficiency: Yes
    Patient Does Not Have a Deficiency of Succinic Semialdehyde Dehydrogenase: No
    Patient Does Not Have a History of Substance Abuse: No
    Patient is Not Using a Sedative Hypnotic: No
    Patient Will Not Be Using with Alcohol: No
    Documentation Requiring Patient to be Enrolled in REMS Success Program: No
    Documentation of prescriber enrollment in REMS program: No
    Prescriber Must Check Patient's Drug History on Controlled Substance Database: No
    Documented Time Period or Frequency of Time That the Precriber Must Regularly See the Patient: N/A
    Diagnosis Type(s): 1 of Excessive daytime sleepiness associated with narcolepsy;Narcolepsy Type 1 (with Cataplexy);Narcolepsy Type 2 (without Cataplexy)
    Documented Diagnosis: Yes
    Patient has >1 Cataplexy Episodes: Yes
    Documented Daily EDS occurrences >= 3 months: Yes
    MSLT <8min with evidence of 2 SOREMP's: Yes
    MSLT with evidence of >= 1 SOREMP's and SOREMP, 15 min from preceeding night PSG: Yes
    CSF Hypocretin-1 Deficiency: Yes
    Prescriber Must See Patient Every 3 Months: No

  • Step Therapy: ST Single Generic

  • Quantity Limit: 1 tablet per 1 day(s).

  • For FAX form click HERE
    Our electronic prior authorization (ePA) process is the preferred method for submitting pharmacy prior authorization requests. Creating an account is free, easy and helps patients get their medications sooner. You can complete the process through your current electronic health record/electronic medical record (EHR/EMR) system or by using one of these ePA sites:
     Log in to Surescripts
     Log in to CoverMyMeds; For details on drug coverage click  HERE;